Cefixime: A Third-Generation Cephalosporin Antibiotic

Select Content Type
Briefs
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
third generation_thumbnail
Detail Image
third generation_mobile
Book Detail
Upload PDF
Cefixime A Third-Generation Cephalosporin Antibiotic.pdf (105.11 KB)
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Cefixime is a third-generation cephalosporin antibiotic used to treat various bacterial infections. This summary highlights key points on Cefixime from the National Cancer Institute (NCI) with detailed information on cefixime's uses, mechanisms, and clinical applications.

Published Date